Predict | Value-Based Contracts

Differentiate products and establish key partnerships.

Unrelenting increases in healthcare costs and disappointing patient outcomes are accelerating the interest in value-based contracts (VBCs).  By putting data and patients at the center of the transformation, VBCs create a foundation for change, an opportunity for real differentiation, and can unlock new win-win partnership opportunities

AI INFORMS ACTION

identify the right opportunities, foster collaboration, and operationalize contracts.

ClosedLoop generates explainable predictions using thousands of auto-generated, clinically relevant contributing factors.

Determine

Determine which pharmaceuticals work best with value-based pricing agreements and identify opportunities for bundled offerings or digital therapeutics that drive outcomes

Assess

Assess specific opportunities with HCO partners using their data and reach consensus on specific cohorts, key outcomes, and standards for specific metrics

Choose

Choose the right treatments and identify the specific patient cohorts and outcomes that align stakeholders

EXPLORE MORE USE CASES

Drug Safety

Payers

Providers

Anticipate and avoid adverse drug reactions.

Telehealth

Digital Health

Payers

Providers

Streamline telehealth offerings and improve outcomes.

Adverse Glycemic Events & Continuous Glucose Monitoring

Providers

Improve glycemic control and avoid adverse outcomes.

Make AI/ML a core element of your care strategy.

Get in touch today to see the ClosedLoop platform in action.